News & Events

26/10/2018
Fidia farmaceutici announces the results of a prospective clinical investigation aimed at assessing the effectiveness and the safety of Hydeal-D vaginal pessaries, composed of an ester of hyaluronic acid, in the treatment of vulvovaginal atrophy in post-menopause women. - Vulvovaginal atrophy in…
28/09/2018

COMPANY ANNOUNCEMENT

• Completion of efficacy and tolerability study
• Full-scale production initiated
• Launch in Italy by the end of 2018

Further to previous communications, regarding the development of a hair loss remedy (aka “Brotzu lotion”) initiated several months ago, we are pleased to announce the completion of the efficacy and tolerability study, following an intensive research program. The study was conducted productively and…
12/06/2018

The acquisition gives an added boost to Fidia’s leadership in the national and international ophthalmology market segment

• Sooft is active in the treatment of all major eye conditions through Sooft, Bioos, Glaucoom, OftaH.T.and Neoox trademarks
• The company owns 27 patents, further bolstering Fidia Pharma Group’s already strong portfolio, consisting of more than 1,100 patents, of which over 700 on hyaluronic acid

Abano Terme (PD), June 11, 2018 – Fidia Pharma Group, an Italian multinational company, leader in the R&D, manufacturing and sales of a wide range of products mainly based on hyaluronic acid, announced today the closing of the acquisition of Sooft, #1 Italian ophthalmic company in Italy , by…
25/04/2018

Poster Title: “Hyaluronan Derivative Hymovis® Increases Cartilage Volume and Type II Collagen Turnover in Osteoarthritis Knee:
Data from MOKHA (MRI, BiOmarkers, Knee, Hymovis®, OsteoArthritis) Study”

• Potential beneficial effect of HYMOVIS® on pain and function
• Structural modifying effect in knee OA with HYMOVIS®

Abano Terme, Italy, April 25, 2018 – Fidia Farmaceutici, a world leader in the research, development and manufacturing of hyaluronic acid (HA)-based products and its wholly owned subsidiary, Fidia Pharma USA Inc., announce that new data will be presented at the Osteoarthritis Research Society…

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- ophthalmology
- wound care
- dermatology
- neurology
- dermo-aesthetics